Cargando…

VIRMA-Dependent N6-Methyladenosine Modifications Regulate the Expression of Long Non-Coding RNAs CCAT1 and CCAT2 in Prostate Cancer

RNA methylation at position N6 in adenosine (m(6)A) and its associated methyltransferase complex (MTC) are involved in tumorigenesis. We aimed to explore m(6)A biological function for long non-coding RNAs (lncRNAs) in prostate cancer (PCa) and its clinical significance. m(6)A and MTC levels in PCa c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Barros-Silva, Daniela, Lobo, João, Guimarães-Teixeira, Catarina, Carneiro, Isa, Oliveira, Jorge, Martens-Uzunova, Elena S., Henrique, Rui, Jerónimo, Carmen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7226055/ https://www.ncbi.nlm.nih.gov/pubmed/32218194 http://dx.doi.org/10.3390/cancers12040771

Ejemplares similares

CCAT: Combinatorial Code Analysis Tool for transcriptional regulation
por: Jiang, Peng, et al.
Publicado: (2014)

Enhancer-derived long non-coding RNAs CCAT1 and CCAT2 at rs6983267 has limited predictability for early stage colorectal carcinoma metastasis
por: Thean, Lai Fun, et al.
Publicado: (2021)

Long non-coding RNAs CCAT1 and CCAT2 in colorectal liver metastases are tumor-suppressive via MYC interaction and might predict patient outcomes
por: Franz, Clemens, et al.
Publicado: (2023)

CCAT2 is an oncogenic long non-coding RNA in pancreatic ductal adenocarcinoma
por: Cai, Yi, et al.
Publicado: (2018)

CCAT 1- A Pivotal Oncogenic Long Non-Coding RNA in Colorectal Cancer
por: Liau, Xiew Leng, et al.
Publicado: (2023)

The component of the m(6)A writer complex VIRMA is implicated in aggressive tumor phenotype, DNA damage response and cisplatin resistance in germ cell tumors
por: Miranda-Gonçalves, Vera, et al.
Publicado: (2021)

Systematic review of health promotion policies or regulations with CCAT theory
por: Purwaningsih, Eni, et al.
Publicado: (2023)

m(6)A RNA modification and its writer/reader VIRMA/YTHDF3 in testicular germ cell tumors: a role in seminoma phenotype maintenance
por: Lobo, João, et al.
Publicado: (2019)

Roles of Long Non-Coding RNA CCAT2 in Cervical Cancer Cell Growth and Apoptosis
por: Wu, Le, et al.
Publicado: (2016)

Knockdown of long non-coding RNA CCAT2 suppressed proliferation and migration of glioma cells
por: Guo, Hua, et al.
Publicado: (2016)

CCAT2, a novel long non-coding RNA in breast cancer: expression study and clinical correlations
por: Redis, Roxana S, et al.
Publicado: (2013)

The long non-coding RNA CCAT2 is up-regulated in ovarian cancer and associated with poor prognosis
por: Huang, Shuying, et al.
Publicado: (2016)

Long Non-Coding RNA CCAT2 Activates RAB14 and Acts as an Oncogene in Colorectal Cancer
por: Wang, Dalu, et al.
Publicado: (2021)

LncRNA CCAT2 promoted osteosarcoma cell proliferation and invasion
por: Yan, Lihua, et al.
Publicado: (2018)

LncRNA CCAT1 is overexpressed in tuberculosis patients and predicts their survival
por: Ye, Taosheng, et al.
Publicado: (2021)

A Promoter in the Coding Region of the Calcium Channel Gene CACNA1C Generates the Transcription Factor CCAT
por: Gomez-Ospina, Natalia, et al.
Publicado: (2013)

Prognostic value of long non-coding RNA CCAT1 expression in patients with cancer: A meta-analysis
por: Shi, Deyao, et al.
Publicado: (2017)

Long Non-coding RNA CCAT1 Acts as an Oncogene and Promotes Sunitinib Resistance in Renal Cell Carcinoma
por: Shan, Liping, et al.
Publicado: (2020)

Vitamin D Suppresses Ovarian Cancer Growth and Invasion by Targeting Long Non-Coding RNA CCAT2
por: Wang, Liye, et al.
Publicado: (2020)

Increased expression of long non-coding RNA CCAT2 predicts poorer prognosis in patients with hepatocellular carcinoma
por: Fu, Changbo, et al.
Publicado: (2019)

Clinicopathological and prognostic value of long non-coding RNA CCAT1 expression in patients with digestive system cancer
por: Yu, Yue, et al.
Publicado: (2023)

Deregulation of N6-Methyladenosine RNA Modification and Its Erasers FTO/ALKBH5 among the Main Renal Cell Tumor Subtypes
por: Guimarães-Teixeira, Catarina, et al.
Publicado: (2021)

Colon Cancer Associated Transcript-1 (CCAT1) Expression in Adenocarcinoma of the Stomach
por: Mizrahi, Ido, et al.
Publicado: (2015)

Expression Study and Clinical Correlations of MYC and CCAT2 in Breast Cancer Patients
por: Sarrafzadeh, Shaghayegh, et al.
Publicado: (2017)

Long non-coding RNA CCAT1 modulates neuropathic pain progression through sponging miR-155
por: Dou, Lidong, et al.
Publicado: (2017)

Correction: Prognostic value of long non-coding RNA CCAT1 expression in patients with cancer: A meta-analysis
por: Shi, Deyao, et al.
Publicado: (2017)

Long non-coding RNA CCAT2 functions as an oncogene in hepatocellular carcinoma, regulating cellular proliferation, migration and apoptosis
por: ZHOU, NING, et al.
Publicado: (2016)

Corrigendum: Long non-coding RNA CCAT1 acts as an oncogene and promotes sunitinib resistance in renal cell carcinoma
por: Shan, Liping, et al.
Publicado: (2023)

LncRNA CCAT1 functions as apoptosis inhibitor in podocytes via autophagy inhibition
por: Su, Yanyan, et al.
Publicado: (2019)

Association of lncRNA CCAT2 and CASC8 Gene Polymorphisms with Hepatocellular Carcinoma
por: Wu, Edie-Rosmin, et al.
Publicado: (2019)

lncRNA CCAT1 promotes bladder cancer cell proliferation, migration and invasion
por: Zhang, Caixiang, et al.
Publicado: (2019)

Serum CCAT2 as a biomarker for adjuvant diagnosis and prognostic prediction of cervical cancer
por: Cao, Xiaoli, et al.
Publicado: (2022)

LncRNA CCAT1 enhances chemoresistance in hepatocellular carcinoma by targeting QKI-5
por: Xia, Chongsheng, et al.
Publicado: (2022)

CCL3 secreted by hepatocytes promotes the metastasis of intrahepatic cholangiocarcinoma by VIRMA-mediated N6-methyladenosine (m(6)A) modification
por: Zhou, Shurui, et al.
Publicado: (2023)

Long non-coding RNA CCAT1 as a diagnostic and prognostic molecular marker in various cancers: a meta-analysis
por: Zhang, Zhihui, et al.
Publicado: (2018)

Knockdown of long non-coding RNA CCAT2 suppresses the progression of thyroid cancer by inhibiting the Wnt/β-catenin pathway
por: Xin, Suping, et al.
Publicado: (2020)

Expression of Concern: Prognostic value of long non-coding RNA CCAT1 expression in patients with cancer: A meta-analysis
Publicado: (2023)

What is beyond LncRNAs in breast cancer: A special focus on colon cancer-associated Transcript-1 (CCAT-1)
por: Selem, Noha A., et al.
Publicado: (2021)

Upregulation of the c-MYC oncogene and adjacent long noncoding RNAs PVT1 and CCAT1 in esophageal squamous cell carcinoma
por: Roohinejad, Zahra, et al.
Publicado: (2023)

AB206. Expression and clinical significance of CCAT2 in renal cell carcinoma and bladder cancer
por: Wu, Song, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_uesfr4ggm4dlfgs2gcodpomdmg